Video Source:

NISS-Merck Virtual Meet-up on Bayesian Statistics in Drug Development

Discussion held April 27, 2020.
Moderated by Don Holder, Executive Director, BARDS, Merck

04:00  Fundamental Advantages of Bayes in Drug Development
Frank Harrell, Professor of Biostatistics at Vanderbilt University’s School of Medicine

26:23  Bayesian Applications for Extrapolation from Adult to Pediatric Data
Amy Xia, Vice President of the Biostatistics, Design & Innovation division at Amgen

49:50  The Value of Bayesian Approaches in the Regulatory Setting
Telba Irony, Deputy Directory of Biostatistics and Epidemiology at the FDA’s Center for Biologics Evaluation and Research

Want to live on the Edge?


Join the conversation

Your email address will not be published. Required fields are marked *

Saving subscription status...


You May Also Like